Newsroom

Jun Yu, MD, Associate Professor of Cardiovascular Sciences at the Lewis Katz School of Medicine, who was recently granted tenure, is working hard to understand the basic science behind a leading cause of heart disease and to discover ways to stop it in its tracks.  

Media outlets, including Healio Rheumatology, HCPLive and Daily Mail, highlighted a new study published in JAMA examining the effect of the IL-1 inhibitor canakinumab (Ilaris) vs. placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19.

The Lewis Katz School of Medicine, home to highly skilled researchers and professors and known for its collaborative atmosphere, has long been on the cutting edge of biomedical research. Now, PhD and MD/PhD students in the Biomedical Sciences Graduate Program at Temple stand to benefit even further from these in-house resources, gaining unprecedented opportunities to learn from researchers across multiple departments, thanks to a new $1 million T32 predoctoral training grant from the National Institute of General Medical Sciences (NIGMS) within the National Institutes of Health (NIH).